<DOC>
	<DOCNO>NCT01827917</DOCNO>
	<brief_summary>The objective study achieve post-marketing protective effect research Speeda® rabies vaccine human use Chengda Bio .</brief_summary>
	<brief_title>The Protection Effect Speeda® Rabies Vaccine Human Use</brief_title>
	<detailed_description>When found injury bitten animal three-level , investigator would enroll participant explain protection making sign informed consent . The patient would inject rabies vaccine follow national regulation , meanwhile investigator would get blood sample detect whether man-killer carry rabies virus .</detailed_description>
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Parent/legal acceptable representative child adult participant willing able understand protocol requirement provide informed consent sign Participant consider good health include body mental status basis report medical history limited physical examination live local ≥ 12 month injure The mankiller could find detect whether carry virus Known bleeding disorder suspect impairment immunologic function , receipt immunosuppressive therapy immunoglobulin since birth Apply passive immunity preparation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>